The Impact of Complementary Feeding on Fecal Microbiota in Exclusively Breast-Fed Infants with Cystic Fibrosis (A Descriptive Study).

Saioa Vicente, Andrea Asensio-Grau, Ana Andrés, María Garriga, Joaquim Calvo-Lerma, Carmen Ribes-Koninckx

Journal: Nutrients 2024;16(23):

PMID: 39683464

Abstract

BACKGROUND/OBJECTIVES

Early life gut microbiota plays a pivotal role in shaping immunity, metabolism, and overall health outcomes. This is relevant in healthy infants but may be even more crucial in infants with chronic devastating diseases, such as cystic fibrosis (CF). While the introduction of solid foods in healthy infants modifies the composition of colonic microbiota, less knowledge is available on those with CF. The aim of this descriptive observational study was to assess the composition of fecal microbiota in six exclusively breast-fed infants with CF, and then explore the changes induced upon the introduction of different foods.

METHODS

two types of fecal samples were collected from each subject: one during the exclusive-breastfeeding period, and the other after incorporating each new food in the ad libitum diet. The microbiota composition was analyzed by 16S rRNA amplicon sequencing.

RESULTS

Wide heterogenicity in the composition at the phylum level (variable proportions of Actinobacteriota, Proteobacteria, and Firmicutes, and the absence of Bacteroidota in all subjects) was found, and different enterotypes were characterized in each subject by the main presence of one genus: in Subject 1 (relative abundance of 54.4%), in Subject 3 (49.1%), in Subjects 4 and 5 (32.7% and 36.9%, respectively), and in Subject 6 (48.9%). The transition to complementary feeding induced variable changes in microbiota composition, suggesting a subject-specific response and highlighting the importance of inter-individual variation.

CONCLUSIONS

Further studies are required to identify which foods contribute to shaping colonic microbiota in the most favorable way for patients with CF using a personalized approach.

Address: ALISOST Research Group, Department of Preventive Medicine, Public Health, Food Sciences, Toxicology and Legal Medicine, Faculty of Pharmacy and Food Sciences, University of Valencia, 46010 Valencia, Spain.; NutriCura PDig Joint Research Unit UPV, La Fe Health Research Institute, 46026 Valencia, Spain.; Cystic Fibrosis Unit, University Hospital Ramón y Cajal, 28034 Madrid, Spain.; NutriCura PDig Joint Research Unit UPV, La Fe Health Research Institute, 46026 Valencia, Spain.; Food UPV, Polytechnic University of Valencia, 46022 Valencia, Spain.; NutriCura PDig Joint Research Unit UPV, La Fe Health Research Institute, 46026 Valencia, Spain.; Celiac Disease and Digestive Immunopathology Research Group, Health Research Institute La Fe, 46026 Valencia, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.